Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-08-15
2006-08-15
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S002000, C560S045000
Reexamination Certificate
active
07091242
ABSTRACT:
The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.
REFERENCES:
patent: 5681820 (1997-10-01), Ruminski et al.
patent: 2003/0216325 (2003-11-01), Saksena et al.
patent: 19962936 (2001-06-01), None
patent: 9619223 (1996-06-01), None
patent: 9926923 (1999-06-01), None
patent: 0000477 (1999-07-01), None
patent: 9933789 (1999-07-01), None
patent: 9937605 (1999-07-01), None
patent: 0000477 (2000-01-01), None
patent: 9937605 (2000-01-01), None
Saksena et al., 2002, CAS: 139:381756.
Bergel, F. et al., “Synthesis of Beta-(p-bis(2-chloroethyl)aminophenyl)-DL-Beta-alanine, a new amino acid derivative with tumour-inhibiting properties”, Chem & Ind. pp. 1487 (1959).
Aberhart, D. et al., “Synthesis of Geometrical Isomers of Beta-Arylamidoacrylic Esters,”. J. Org. Chem. 46, 3749-3751 (1981).
Johnson, J.M., “Synthesis of Beta(m-bis(2-Chloroethyl)aminophenyl)-DL-Beta-alanine”, Chem & Ind., 966-967, (1960).
Albers Markus
Bacon Kevin
Fischer Rüdiger
Hasegawa Haruki
Hessler Gerhard
Bayer Aktiengesellschaft
McKane Joseph K.
Shiao Robert
LandOfFree
Beta-amino acid derivatives as integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-amino acid derivatives as integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-amino acid derivatives as integrin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3621002